Shandong Weigao Group Medical Polymer Co. Ltd. (SHWGF)
0.4419
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.968B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -39.76% |
| Valuation | |
| PE Ratio | 8.964 |
| PE Ratio (Forward) | |
| PS Ratio | 1.077 |
| Price to Book Value | 1.318 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0137 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 80.93% |
Profile
| Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. It operates through the following segments: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others. The Medical Device Products segment produces and sells clinical care, wound management, medical testing, anesthesia, surgical related products, and other consumables. The Orthopaedic Products segment focuses on the provision of orthopaedic products. The Interventional Products segment consists of tumour and blood vessel interventional instruments. The Pharma Packaging Products includes pre-filled syringes and flushing syringes. The Blood Management Products segment refers to blood collection, irradiation, storage, separation, and sterilization products. The Others segment pertains to the finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China. |
| URL | http://www.weigaogroup.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shandong |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 27, 2026 (est.) |
| Last Earnings Release | Mar. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 23, 2025 |
Profile
| Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. It operates through the following segments: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others. The Medical Device Products segment produces and sells clinical care, wound management, medical testing, anesthesia, surgical related products, and other consumables. The Orthopaedic Products segment focuses on the provision of orthopaedic products. The Interventional Products segment consists of tumour and blood vessel interventional instruments. The Pharma Packaging Products includes pre-filled syringes and flushing syringes. The Blood Management Products segment refers to blood collection, irradiation, storage, separation, and sterilization products. The Others segment pertains to the finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China. |
| URL | http://www.weigaogroup.com |
| Investor Relations URL | N/A |
| HQ State/Province | Shandong |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 27, 2026 (est.) |
| Last Earnings Release | Mar. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 23, 2025 |